Cancer claims more than 10 million lives every year globally. Research shows that detecting cancer early can greatly improve ...
Utepreva LLC today announced the launch of the Utepreva Endometrial Sampler, a patented, FDA 510(k)-cleared, single-use endometrial sampling device engineered to enhance tissue capture and support ...
The FDA 510(k)-cleared Utepreva Endometrial Sampler, a single-use device designed to support early diagnostic evaluation of ...
Histopathologic Yields and Concordance of In-Bore MRI-targeted Biopsy for Prostate Cancer Diagnosis.
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. This voice experience is generated by AI. Learn more. This voice ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Liquid biopsies look for cancer signals in the blood, and while the tests for early ...
The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily ...
Some claim the new multi-cancer detection tests will “revolutionize” cancer screening. Others fear the “worried well” will succumb to slick marketing and subpar tests and overwhelm both primary care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results